s6y
Company name or ticker
Search
Ballantyne Charles Evan
4
Synthetic Biologics, Inc.: Statement of changes in beneficial ownership of securities
Filed
Monday, April 21, 2014
Period
Apr 17, 2014
Accession number
0001144204-14-023890
Documents
FORM 4
4
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header